Literature DB >> 31375049

Surgical treatment of large adnexal masses: a retrospective analysis of 330 consecutive cases.

Jvan Casarin1,2, Antonio Simone Laganà1, Stefano Uccella3, Antonella Cromi1, Ciro Pinelli1, Baldo Gisone1, Camilla Borghi1, Selene Cominotti1, Simone Garzon1, Matteo Morotti2, Roberto Tozzi2, Fabio Ghezzi1.   

Abstract

Introduction: In the present study, perioperative outcomes of laparoscopy (LPS) were compared to open surgery (OS) for the treatment of large adnexal masses (AM).Material and methods: Retrospective observational cohort study. Data of consecutive patients who underwent ovarian cystectomy or salpingo-oophorectomy for large AM (diameter ≥10 cm) at a referral minimally invasive gynecologic center were analyzed. Propensity score match (PSM) analysis was used to minimize covariate imbalances between the two groups.
Results: Overall 330 patients, 285 (86.4%) LPSs and 45 (13.6%) OSs were included. PSM showed LPS (vs. OS) to be associated with less intraoperative blood loss (mL: 131.1 ± 52.6 vs. 545.5 ± 101.2; p = .007), shorter operative time (min: 84.8 ± 77.9 vs. 123.7 ± 70.1; p < .001), but higher rate of spillage (54.5% vs. 12.1%; p < .001). Among the LPS group, a positive correlation between AM size and both conversion to open surgery and need for mini-laparotomy was found (p < .05).Conclusions: An accurate patient selection, a dedicated workup, and an appropriate counselling are mandatory before LPS for large AM. The increased risks of intraoperative spillage associated with the minimally invasive approach should be acknowledged.

Entities:  

Keywords:  adnexal mass; laparoscopy; open surgery; ovarian cyst; spillage

Mesh:

Year:  2019        PMID: 31375049     DOI: 10.1080/13645706.2019.1649700

Source DB:  PubMed          Journal:  Minim Invasive Ther Allied Technol        ISSN: 1364-5706            Impact factor:   2.442


  5 in total

1.  Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor.

Authors:  Jun-Hyeok Kang; Joseph J Noh; Soo Young Jeong; Jung In Shim; Yoo-Young Lee; Chel Hun Choi; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae; Hyun-Soo Kim; Tae-Joong Kim
Journal:  Front Oncol       Date:  2020-09-16       Impact factor: 6.244

Review 2.  Secondary and tertiary ovarian cancer recurrence: what is the best management?

Authors:  Simone Garzon; Antonio Simone Laganà; Jvan Casarin; Ricciarda Raffaelli; Antonella Cromi; Massimo Franchi; Fabio Barra; Ibrahim Alkatout; Simone Ferrero; Fabio Ghezzi
Journal:  Gland Surg       Date:  2020-08

3.  Malignant epithelioid neoplasm of the ileum with ACTB-GLI1 fusion mimicking an adnexal mass.

Authors:  Marco Ambrosio; Agnese Virgilio; Antonio Raffone; Alessandro Arena; Diego Raimondo; Andrea Alletto; Renato Seracchioli; Paolo Casadio
Journal:  BMC Womens Health       Date:  2022-04-06       Impact factor: 2.809

Review 4.  The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age.

Authors:  Luigi Della Corte; Antonio Mercorio; Paolo Serafino; Francesco Viciglione; Mario Palumbo; Maria Chiara De Angelis; Maria Borgo; Cira Buonfantino; Marina Tesorone; Giuseppe Bifulco; Pierluigi Giampaolino
Journal:  Front Surg       Date:  2022-08-23

Review 5.  Borderline ovarian tumours: management in the era of fertility-sparing surgery.

Authors:  Mattia Maramai; Fabio Barra; Mario Valenzano Menada; Sara Stigliani; Melita Moioli; Sergio Costantini; Simone Ferrero
Journal:  Ecancermedicalscience       Date:  2020-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.